• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

酒石酸托特罗定经皮给药用于膀胱过度活动症治疗的体内外评价

Transdermal delivery of tolterodine tartrate for overactive bladder treatment: In vitro and in vivo evaluation.

作者信息

Rajabalaya Rajan, Mun Chung Yee, Chellian Jestin, Chakravarthi Srikumar, David Sheba R

机构信息

.

出版信息

Acta Pharm. 2017 Sep 1;67(3):325-339. doi: 10.1515/acph-2017-0027.

DOI:10.1515/acph-2017-0027
PMID:28858835
Abstract

The purpose of the study was to develop a transdermal tolterodine tartrate (TT) patch and to analyse its efficacy for overactive bladder (OAB) treatment. Patches were prepared using various polymers and plasticizers via the solvent casting method. The patches were characterized for tensile strength, thickness, moisture content, modulus of elasticity and water absorption capacity. Differential scanning calorimetry and Fourier transform infrared analyses were also performed. To determine patch effectiveness, in vitro release, permeation and animal studies were performed. The patches showed satisfactory percentage of release, up to 89.9 %, and their mechanical properties included thickness (0.10-0.15 mm), tensile strength (4.62-9.98 MPa) and modulus of elasticity (20-29 MPa). There were no significant interactions between TT and other excipients. Animal studies indicated that the TT patch reduced the incidence of side effects; however, studies of longer duration are required to determine the effectiveness in treating OAB.

摘要

本研究的目的是开发一种酒石酸托特罗定(TT)透皮贴剂,并分析其治疗膀胱过度活动症(OAB)的疗效。通过溶剂浇铸法使用各种聚合物和增塑剂制备贴剂。对贴剂的拉伸强度、厚度、水分含量、弹性模量和吸水能力进行了表征。还进行了差示扫描量热法和傅里叶变换红外分析。为了确定贴剂的有效性,进行了体外释放、渗透和动物研究。贴剂的释放百分比令人满意,高达89.9%,其机械性能包括厚度(0.10 - 0.15毫米)、拉伸强度(4.62 - 9.98兆帕)和弹性模量(20 - 29兆帕)。TT与其他辅料之间没有显著相互作用。动物研究表明,TT贴剂降低了副作用的发生率;然而,需要进行更长时间的研究来确定其治疗OAB的有效性。

相似文献

1
Transdermal delivery of tolterodine tartrate for overactive bladder treatment: In vitro and in vivo evaluation.酒石酸托特罗定经皮给药用于膀胱过度活动症治疗的体内外评价
Acta Pharm. 2017 Sep 1;67(3):325-339. doi: 10.1515/acph-2017-0027.
2
Inhibition of salivary secretion by tolterodine transdermal patch.托特罗定透皮贴剂抑制唾液分泌。
Arch Pharm Res. 2017 Dec;40(12):1455-1463. doi: 10.1007/s12272-017-0988-9. Epub 2017 Nov 20.
3
Tolterodine Tartrate Loaded Cationic Elastic Liposomes for Transdermal Delivery: In Vitro, Ex Vivo, and In Vivo Evaluations.酒石酸托特罗定载阳离子弹性脂质体经皮给药:体外、离体和体内评价。
Pharm Res. 2024 Aug;41(8):1683-1702. doi: 10.1007/s11095-024-03741-y. Epub 2024 Jul 24.
4
Hansen solubility parameters and quality-by-design oriented optimized cationic nanoemulsion for transdermal drug delivery of tolterodine tartrate.基于 Hansen 溶解度参数和质量源于设计的托特罗定酒石酸盐经皮给药阳离子型纳米乳的优化。
Int J Pharm. 2024 Oct 25;664:124611. doi: 10.1016/j.ijpharm.2024.124611. Epub 2024 Aug 30.
5
Preparation, characterization and pharmacological evaluation of tolterodine hydrogels for the treatment of overactive bladder.制备、表征及多沙唑嗪水凝胶的药理学评价治疗膀胱过度活动症。
Int J Pharm. 2013 Sep 15;454(1):532-8. doi: 10.1016/j.ijpharm.2013.07.041. Epub 2013 Jul 23.
6
Clinical safety, tolerability and efficacy of combination tolterodine/pilocarpine in patients with overactive bladder.托特罗定/毛果芸香碱联合用药治疗膀胱过度活动症患者的临床安全性、耐受性及疗效
Int J Clin Pract. 2014 Aug;68(8):986-94. doi: 10.1111/ijcp.12409. Epub 2014 Mar 25.
7
Synergistic effect of iontophoresis and chemical enhancers on transdermal permeation of tolterodine tartrate for the treatment of overactive bladder.经皮给药治疗膀胱过度活动症中离子电渗和化学渗透促进剂对酒石酸托特罗定渗透的协同作用。
Int Braz J Urol. 2013 Jan-Feb;39(1):63-75; discussion 76. doi: 10.1590/S1677-5538.IBJU.2013.01.09.
8
Patient-reported outcomes in patients with overactive bladder treated with mirabegron and tolterodine in a prospective, double-blind, randomized, two-period crossover, multicenter study (PREFER).一项前瞻性、双盲、随机、两周期交叉、多中心研究(PREFER)显示,米拉贝隆和托特罗定治疗膀胱过度活动症患者的患者报告结局。
Health Qual Life Outcomes. 2018 Apr 19;16(1):69. doi: 10.1186/s12955-018-0892-0.
9
Combined Tolterodine and Vaginal Estradiol Cream for Overactive Bladder Symptoms After Randomized Single-Therapy Treatment.随机单药治疗后联合使用托特罗定和阴道雌二醇乳膏治疗膀胱过度活动症症状
Female Pelvic Med Reconstr Surg. 2016 Jul-Aug;22(4):254-60. doi: 10.1097/SPV.0000000000000256.
10
Silicone adhesive, a better matrix for tolterodine patches-a research based on in vitro/in vivo studies.硅酮胶,一种更好的托特罗定贴片基质——基于体外/体内研究的探索。
Drug Dev Ind Pharm. 2012 Aug;38(8):1008-14. doi: 10.3109/03639045.2011.637049. Epub 2011 Nov 29.

引用本文的文献

1
HSPiP and QbD oriented optimized nanocubosomes for ameliorated absorption of tolterodine tartrate: and evaluations.基于HSPiP和质量源于设计理念的优化纳米立方粒用于改善酒石酸托特罗定的吸收及评价
Int J Pharm X. 2025 Aug 18;10:100378. doi: 10.1016/j.ijpx.2025.100378. eCollection 2025 Dec.
2
Tolterodine Tartrate Loaded Cationic Elastic Liposomes for Transdermal Delivery: In Vitro, Ex Vivo, and In Vivo Evaluations.酒石酸托特罗定载阳离子弹性脂质体经皮给药:体外、离体和体内评价。
Pharm Res. 2024 Aug;41(8):1683-1702. doi: 10.1007/s11095-024-03741-y. Epub 2024 Jul 24.
3
Drug Delivery Approaches for Managing Overactive Bladder (OAB): A Systematic Review.
治疗膀胱过度活动症(OAB)的药物递送方法:一项系统评价
Pharmaceuticals (Basel). 2021 Apr 26;14(5):409. doi: 10.3390/ph14050409.